UK-based contract development and manufacturing company Almac Group’s unit Almac Clinical Services has announced that it had digitised its on-site auditing process and unveiled a virtual auditing solution for global clients.
Almac has digitised its conventional auditing process in order to ensure continued regulatory compliance during the current market conditions as a result of the Covid-19 pandemic.
The new solution is designed to maintain good manufacturing practices (GMP) standards, while protecting employees and upholding social corporate responsibility (CSR) to suppliers.
Through the new virtual auditing solution, clients across the world can realise clear advantages, such as saving time and money.
Almac Clinical Services managing director and president Robert Dunlop said: “With a changing clinical trial landscape and the need for an adaptable business model due to impacts of Covid-19, Almac continues to innovate and provide solutions for clients.
“Our clients are supporting complex, global clinical studies, and we understand the pressures they face at this time. In fulfilling our obligation to ensure quality oversight, it is important Almac continues to provide an environment where traditional systems and procedures can be suitably challenged and adapted.”
During the current pandemic crisis, Almac is offering a set of alternative auditing strategies for its clients to ease clinical trials that are underway and ‘accelerate timelines’ for coronavirus studies.
In June this year, Almac Group’s unit Almac Clinical Technologies introduced an advanced interactive response technology (IRT).
In March 2019, Almac Group unveiled a unified clinical trial supply solution to improve the experience for sponsors.